Investigators found data from the National Notifiable Diseases Surveillance System that showed hepatitis C virus infection rates doubled among women of reproductive age between 2006 and 2014.
Further patient advocacy is needed to ensure that recipients of HCV-infected organs have access to direct-acting antivirals as early as possible, including in a prophylactic manner, if data continue to support its benefit.
Although hepatic vein pressure gradient measurement is an accurate method for evaluation of portal HTN, this technique is invasive and not widely available.
The opioid epidemic has fueled the transmission of HCV, particularly among younger persons, who are often unaware of their risks and prevented from receiving timely treatment due to a variety of care barriers, even in settings ideally suited to identifying and treating HCV.
Evidence continues to mount that a specific strain of adenovirus could be implicated in a wave of American children who have developed acute hepatitis of unknown origin.
Researchers assessed the characteristics and distribution of hepatitis C virus (HCV) genotypes among individuals with confirmed HCV infection who donated blood during a 16-year period.
Researchers assessed whether the rate of treatment initiations for hepatitis C virus infection among patients participating in a methadone treatment program increased after the implementation of a hepatology clinic.
Researchers conducted a study to determine whether the addition of a default screening order in the electronic health record increases the rate of hepatitis C virus screening among hospitalized patients.
Researchers evaluated the risk for alcohol relapse 2 years after patients received an early liver transplant for alcohol-related hepatitis vs standard liver transplant for alcohol-related cirrhosis.
In this study, researchers assessed the nationwide rate of testing and treatment initiations for hepatitis C virus infection in the United States following the onset of the COVID-19 pandemic through the end of 2020.
Investigators conducted a study to determine the effect of syringes with fixed needles vs those with detachable needles on the risk for hepatitis C virus transmission among people who use injectable drugs.
Among patients with chronic HCV infection, those who have sustained SVR to DAA therapy have reductions in measures of health care utilization compared with those who do not receive DAA therapy.
